Dopaminergic regulation of striatal proenkephalin mrna and prodynorphin mrna: Contrasting effects of d1 and d2 antagonists
- 1 May 1988
- journal article
- research article
- Published by Elsevier in Neuroscience
- Vol. 25 (2) , 525-532
- https://doi.org/10.1016/0306-4522(88)90256-4
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Reduction of striatal dopaminergic neurotransmission elevates striatal proenkephalin mRNAEuropean Journal of Pharmacology, 1986
- Neurophysiological evidence that D-1 dopamine receptor blockade attenuates postsynaptic but not autoreceptor-mediated effects of dopamine agonistsEuropean Journal of Pharmacology, 1986
- Selective D-1 dopamine receptor increase following chronic treatment with SCH 23390European Journal of Pharmacology, 1985
- Chemical and structural analysis of the relation between cortical inputs and tyrosine hydroxylase-containing terminals in rat neostriatumBrain Research, 1984
- Localization of immunoreactive enkephalins in GABA synthesizing neurons of the rat neostriatumBrain Research, 1984
- The electrophysiology of dopamine (D2) receptors: A study of the actions of dopamine on corticostriatal transmissionNeuroscience, 1983
- Pre- and postsynaptic striatal dopamine receptors: differential sensitivity to apomorphine inhibition of [3H]dopamine and [14C]GABA release in vitroJournal of Pharmacy and Pharmacology, 1980
- The action of dopamine on rat caudate neurones intracellularly recordedNeuroscience Letters, 1978
- Evidence for a long Leu-enkephalin striopallidal pathway in rat brainNature, 1978
- Antischizophrenic Drugs: Chronic Treatment Elevates Dopamine Receptor Binding in BrainScience, 1977